Last updated on January 2019

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03334396

Contact Investigators or Research Sites near you

Start Over

There may be multiple sites ...

Sumire Dermatology Clinic
Edogawa-ku, Japan
  Connect »

There may be multiple sites ...

Kawashima Dermatology Clinic
Ichikawa-shi, Japan
  Connect »

There may be multiple sites ...

Nihonbashi Sakura Clinic
Chuo-ku, Japan
  Connect »

There may be multiple sites ...

Iidabashi Clinic
Chiyoda-ku, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.